Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001897612-25-000105
Filing Date
2025-02-14
Accepted
2025-02-14 09:45:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5857
  Complete submission text file 0001897612-25-000105.txt   7692
Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202
Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address C/O SELECT MEDICAL CORPORATION 4714 GETTYSBURG RD., P.O. BOX 2034 MECHANICSBURG PA 17055
Business Address C/O SELECT MEDICAL CORPORATION 4714 GETTYSBURG RD., P.O. BOX 2034 MECHANICSBURG PA 17055 717-972-1100
Concentra Group Holdings Parent, Inc. (Subject) CIK: 0002014596 (see all company filings)

EIN.: 301006613 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94607 | Film No.: 25624116
SIC: 8093 Services-Specialty Outpatient Facilities, NEC
(CF Office: 08 Industrial Applications and Services)